Crispr Therapeutics Ag (CRSP)

Depreciation & Amortization

$18.69M

TTM · Period ending: · USD

CRSP logo

CRSP Depreciation & Amortization

Latest reported$18.69M
CRSP TTM Depreciation & Amortization ($127.00K → $18.69M)
High-resolution chart · PNG

CRSP depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
18,693,000
19,062,000
19,479,000
18,660,000
18,966,000
19,162,000
19,259,000
19,317,000
19,503,000
19,619,000
19,837,000
20,783,000
20,876,000
23,184,000
24,172,000
24,587,000
24,893,000
21,277,000
17,953,000
14,258,000
11,269,000
9,808,000
9,184,000
8,050,000
6,998,000
6,004,000
4,725,000
4,238,000
3,838,000
3,505,000
3,519,000
3,380,000
3,289,000
3,130,000
3,024,000
2,630,000
2,074,000
1,539,000
925,000
572,000
376,000
219,000
127,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.